The IMPROVE Study-IMPact of a Regulated ADC System
IMPROVE
IMPact of a Regulated ADC System On Medication Distribution and Administration VariablEs
1 other identifier
observational
120
1 country
1
Brief Summary
An automated dispensing cabinet (ADC) is a computerized drug storage device or cabinet designed for hospitals. ADCs allow medications to be stored and dispensed near the point of care while controlling and tracking drug distribution.This study seeks to obtain quantitative measurements of the impact of the regulated ADC System installed in select high volume units throughout the hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2014
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2014
CompletedFirst Posted
Study publicly available on registry
August 29, 2014
CompletedStudy Start
First participant enrolled
September 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedMarch 17, 2015
March 1, 2015
3 months
August 8, 2014
March 16, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Medication Administered in Error
Medication error rates for heparin and insulin pre-install of regulated ADC system compared to post installation. For each drug, heparin and insulin, the number of medication errors will be enumerated based on event type of the voluntary reporting event report data. For each drug, medication error rates will be calculated by dividing the number medication errors by the number of medication orders multiplied by 1,000. Comparison of medication error rates pre-install and post-install will be conducted using simple Poisson regression analysis obtained in, results of which will be expressed as incidence rate ratio (IRR) and 95% confidence intervals (CI).
six months
Secondary Outcomes (1)
Timeliness of medication administration
six months
Eligibility Criteria
Number of Participants by Group * Children (Minor Subjects): 0 * Cognitively Impaired Participants:0 * Employees and Students: 120 * Patients: 25238 * Prisoners: 0 * Normal Healthy Volunteers: 0 * Pregnant Women-Human Fetuses: 0 * Wards: 0
You may qualify if:
- Subjects treated at study site in units where regulated ADC System was installed where greater number of medications is administered due to patient volume per nurse assignment or where greater throughput occurs
- Time-sensitive scheduled medications administered on units where administration includes the use of the medication label printer
- Piperacillin and tazobactam for injection, USP (United States Pharmacopeia)
- All IV antibiotics
- Insulin
- Heparin
You may not qualify if:
- Medication administration data prior to January 1, 2013;
- Medication administration data after March 31, 2013 through December 31, 2013;
- Medication administration data after March 31, 2014.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hackensack Meridian Healthlead
- Omnicellcollaborator
Study Sites (1)
Hackensack University Medical center
Hackensack, New Jersey, 07601, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudia Douglas, DNP
Hackensack Meridian Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2014
First Posted
August 29, 2014
Study Start
September 1, 2014
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
March 17, 2015
Record last verified: 2015-03